XOVOLTIB 30MG TABLET
| Product Name | Xovoltib 30mg Tablet |
| Active Ingredient | Afatinib |
| Strength | 30mg |
| Dosage Form | Tablet |
| Therapeutic Class | Tyrosine Kinase Inhibitor |
| Indication | EGFR-Positive Non-Small Cell Lung Cancer |
| Administration Route | Oral |
| Packaging | Blister Pack |
| Storage | Store below 25Β°C in a dry place |
| Prescription | Required |
XOVOLTIB 30MG TABLET
Xovoltib 30mg Tablet is a prescription anticancer medication used as part of targeted therapy for specific types of cancer, as determined by an oncologist. It works by interfering with cancer cell growth and proliferation pathways, helping to slow disease progression. This targeted therapy is administered under strict medical supervision to ensure safety and optimal therapeutic outcomes.
Xovoltib 30mg Tablet is indicated for patients with cancers where targeted treatment is appropriate, offering a focused approach compared to traditional chemotherapy. By selectively acting on abnormal cellular pathways, this anticancer product helps limit tumor growth while minimizing effects on healthy tissues. Regular monitoring by healthcare professionals is essential to optimize efficacy and manage any potential side effects.
Xovoltib 30 mg Tablet is manufactured in WHO-GMP certified facilities and is suitable for hospital supply, oncology centers, and bulk or export distribution. This trusted product plays a vital role in modern cancer therapy, providing patients with an effective and safe option for managing disease progression through targeted treatment.
Product Features
- Targeted anticancer therapy tablet
- Used in the treatment of specific cancers
- Helps inhibit cancer cell growth and spread
- Oral tablet for convenient administration
- Suitable for long-term therapy as prescribed
- Prescription-only oncology medication
How It Helps
- Blocks cancer cell growth and proliferation pathways
- Helps slow disease progression in targeted cancers
- Supports long-term cancer management under medical supervision
- Minimizes impact on healthy cells compared to traditional chemotherapy

Reviews
There are no reviews yet.